Sex differences in mesenteric endothelial function of streptozotocin-induced diabetic rats: A shift in the relative importance of EDRFs

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 303, Issue 10, 2012, Pages

  Zhang, Rui ^a   Thor, Der ^a   Han, Xiaoyuan ^a   Anderson, Leigh ^b   Rahimian, Roshanak ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Diabetes; Endothelium derived hyperpolarizing factor; Mesenteric arteries; Nitric oxide; Sex

Indexed keywords

ACETYLCHOLINE; BARIUM CHLORIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED RELAXING FACTOR; INDOMETACIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; OUABAIN; PHENYLEPHRINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; MALE; MESENTERIC ARTERY; MESENTERY BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; STREPTOZOCIN DIABETES; VASCULAR ENDOTHELIUM;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; ENZYME INHIBITORS; EPOPROSTENOL; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MEMBRANE GLYCOPROTEINS; MESENTERIC ARTERIES; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; RISK FACTORS; RNA, MESSENGER; SEX FACTORS; SIGNAL TRANSDUCTION; STREPTOZOCIN; VASODILATION; VASODILATOR AGENTS;

EID: 84869163401     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00327.2012     Document Type: Article

References (98)

1. Abboud K, Bassila JC, Ghali-Ghoul R, Sabra R. Temporal changes in vascular reactivity in early diabetes mellitus in rats: role of changes in endothelial factors and in phosphodiesterase activity. Am J Physiol Heart Circ Physiol 297: H836-H845, 2009.
2. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109: 227-233, 2004.
3. Anderson LC, Martin DJ, Phillips DL, Killpack KJ, Bone SE, Rahimian R. The influence of gender on parasympathetic vasodilatation in the submandibular gland of the rat. Exp Physiol 91: 435-444, 2006.
4. Aviles-Santa L, Salinas K, Adams-Huet B, Raskin P. Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitus. J Investig Med 54: 20-31, 2006.
5. Bardal S, Misurski D, Qiu X, Desai K, McNeill JR. Chronic treatment with vascular endothelial growth factor preserves agonist-evoked vascular responses in the streptozotocin-induced diabetic rat. Diabetologia 49: 811-818, 2006.
6. Bardell AL, MacLeod KM. Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocindiabetic rats. J Pharmacol Exp Ther 296: 252-259, 2001.
7. Bhardwaj R, Moore PK. Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J Pharm Pharmacol 40: 739-742, 1988.
8. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci USA 97: 9747-9752, 2000.
9. Brands MW, Fitzgerald SM. Acute endothelium-mediated vasodilation is not impaired at the onset of diabetes. Hypertension 32: 541-547, 1998.
10. Brown RA, Walsh MF, Ren J. Influence of gender and diabetes on vascular and myocardial contractile function. Endocr Res 27: 399-408, 2001
11. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
12. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24: 471-478, 2003.
13. Chen K, Kirber MT, Xiao H, Yang Y, Keaney JF Jr. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol 181: 1129-1139, 2008.
14. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96: 25-28, 1997.
15. Csanyi G, Lepran I, Flesch T, Telegdy G, Szabo G, Mezei Z. Lack of endothelium-derived hyperpolarizing factor (EDHF) up-regulation in endothelial dysfunction in aorta in diabetic rats. Pharmacol Rep 59: 447-455, 2007.
16. Davel AP, Rossoni LV, Vassallo DV. Effects of ouabain on the pressor response to phenylephrine and on the sodium pump activity in diabetic rats. Eur J Pharmacol 406: 419-427, 2000.
17. De Vriese AS, Van de Voorde J, Blom HJ, Vanhoutte PM, Verbeke M, Lameire NH. The impaired renal vasodilator response attributed to endothelium-derived hyperpolarizing factor in streptozotocin-induced diabetic rats is restored by 5-methyltetrahydrofolate. Diabetologia 43: 1116-1125, 2000.
18. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963-974, 2000.
19. Delles C, Schneider MP, Oehmer S, Fleischmann EH, Schmieder RE. L-arginine-induced vasodilation of the renal vasculature is not altered in hypertensive patients with type 2 diabetes. Diabetes Care 26: 1836-1840, 2003
20. Di Carli MF, Afonso L, Campisi R, Ramappa P, Bianco-Batlles D, Grunberger G, Schelbert HR. Coronary vascular dysfunction in premenopausal women with diabetes mellitus. Am Heart J 144: 711-718, 2002
21. Dora KA, Doyle MP, Duling BR. Elevation of intracellular calcium in smooth muscle causes endothelial cell generation of NO in arterioles. Proc Natl Acad Sci USA 94: 6529-6534, 1997.
22. Dora KA, Hinton JM, Walker SD, Garland CJ. An indirect influence of phenylephrine on the release of endothelium-derived vasodilators in rat small mesenteric artery. Br J Pharmacol 129: 381-387, 2000.
23. Doughty JM, Plane F, Langton PD. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. Am J Physiol Heart Circ Physiol 276: H1107-H1112, 1999.
24. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269-272, 1998.
25. Edwards G, Feletou M, Weston AH. Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflügers Arch 459: 863-879, 2010.
26. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 93: 515-524, 1988.
27. Feletou M. EDHF: new therapeutic targets? Pharmacological Research 49: 565-580, 2004.
28. Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A. Alterations in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats. Br J Pharmacol 121: 1383-1391, 1997.
29. Gao X. Endothelium-derived hyperpolarizing factor and diabetes. World J Cardiol 3: 25-31, 2011.
30. Goel A, Zhang Y, Anderson L, Rahimian R. Gender difference in rat aorta vasodilation after acute exposure to high glucose: involvement of protein kinase C beta and superoxide but not of Rho kinase. Cardiovasc Res 76: 351-360, 2007.
31. Goel A, Thor D, Anderson L, Rahimian R. Sexual dimorphism in rabbit aortic endothelial function under acute hyperglycemic conditions and gender-specific responses to acute 17β-estradiol. Am J Physiol Heart Circ Physiol 294: H2411-H2420, 2008.
32. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26-32, 2000.
33. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
34. Hattori Y, Kawasaki H, Abe K, Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol Heart Circ Physiol 261: H1086-H1094, 1991.
35. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: E14-E22, 2001
36. Hu G. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46: 608-617, 2003.
37. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88: 2510-2516, 1993.
38. Kakkar R, Mantha SV, Kalra J, Prasad K. Time course study of oxidative stress in aorta and heart of diabetic rat. Clin Sci (Lond) 91: 441-448, 1996.
39. Kamata K, Hosokawa M, Matsumoto T, Kobayashi T. Acetylcholineinduced vasodilation in the perfused kidney of the streptozotocin-induced diabetic rat: role of prostacyclin. J Smooth Muscle Res 42: 159-170, 2006.
40. Keung W, Vanhoutte PM, Man RY. Nongenomic responses to 17betaestradiol in male rat mesenteric arteries abolish intrinsic gender differences in vascular responses. Br J Pharmacol 146: 1148-1155, 2005.
41. Kitayama J, Faraci FM, Gunnett CA, Heistad DD. Impairment of dilator responses of cerebral arterioles during diabetes mellitus: role of inducible NO synthase. Stroke 37: 2129-2133, 2006.
42. 2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats. Am J Physiol Heart Circ Physiol 287: H135-H143, 2004.
43. Komori K, Lorenz RR, Vanhoutte PM. Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle. Am J Physiol Heart Circ Physiol 255: H207-H212, 1988.
44. Leo CH, Joshi A, Woodman OL. Short-term type 1 diabetes alters the mechanism of endothelium-dependent relaxation in the rat carotid artery. Am J Physiol Heart Circ Physiol 299: H502-H511, 2010.
45. Leo CH, Hart JL, Woodman OL. Impairment of both nitric oxidemediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes. Br J Pharmacol 162: 365-377, 2011
46. Li M, Stallone JN. Estrogen potentiates vasopressin-induced contraction of female rat aorta by enhancing cyclooxygenase-2 and thromboxane function. Am J Physiol Heart Circ Physiol 289: H1542-H1550, 2005.
47. MacAllister RJ, Calver AL, Collier J, Edwards CM, Herreros B, Nussey SS, Vallance P. Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect? Clin Sci (Lond) 89: 183-190, 1995.
48. Maejima K, Nakano S, Himeno M, Tsuda S, Makiishi H, Ito T, Nakagawa A, Kigoshi T, Ishibashi T, Nishio M, Uchida K. Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications. J Diabetes Complications 15: 135-143, 2001.
49. Makino A, Ohuchi K, Kamata K. Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat. Br J Pharmacol 130: 549-556, 2000.
50. Martinez-Nieves B, Dunbar JC. The effect of diabetes and sex on nitric oxide-mediated cardiovascular dynamics. Exp Biol Med (Maywood) 226: 37-42, 2001.
51. Matsumoto T, Kakami M, Kobayashi T, Kamata K. Gender differences in vascular reactivity to endothelin-1 (1-31) in mesenteric arteries from diabetic mice. Peptides 29: 1338-1346, 2008.
52. McCulloch AI, Bottrill FE, Randall MD, Hiley CR. Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br J Pharmacol 120: 1431-1438, 1997.
53. McCulloch AI, Randall MD. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed. Br J Pharmacol 123: 1700-1706, 1998.
54. 1-adrenergic responses in rat mesenteric arteries. Am J Physiol Heart Circ Physiol 284: H1737-H1743, 2003.
55. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulindependent) diabetes mellitus. Diabetologia 35: 771-776, 1992.
56. Miller AA, Drummond GR, Mast AE, Schmidt HH, Sobey CG. Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: role of estrogen. Stroke 38: 2142-2149, 2007.
57. Miller VM. Sex-based differences in vascular function. Womens Health (Lond Engl) 6: 737-752, 2010.
58. Muller PY, Janovjak H, Miserez AR, Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: 1372-1374, 1376, 1378-1379, 2002.
59. Nacci C, Tarquinio M, De Benedictis L, Mauro A, Zigrino A, Carratu MR, Quon MJ, Montagnani M. Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature. Endocrinology 150: 849-861, 2009.
60. Nawate S, Fukao M, Sakuma I, Soma T, Nagai K, Takikawa O, Miwa S, Kitabatake A. Reciprocal changes in endothelium-derived hyperpolarizing factor-and nitric oxide-system in the mesenteric artery of adult female rats following ovariectomy. Br J Pharmacol 144: 178-189, 2005.
61. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286: R233-R249, 2004.
62. Ozkan MH, Uma S. Does endothelium-derived hyperpolarizing factor play a role in endothelium-dependent component of electrical field stimulation-induced vasorelaxation of rat mesenteric arterial rings? J Cardiovasc Pharmacol 53: 30-37, 2009.
63. Pak KJ, Geary GG, Duckles SP, Krause DN. Male-female differences in the relative contribution of endothelial vasodilators released by rat tail artery. Life Sci 71: 1633-1642, 2002.
64. Pannirselvam M, Ding H, Anderson TJ, Triggle CR. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Eur J Pharmacol 551: 98-107, 2006.
65. 1-adrenoceptors in the distal mesenteric arteries of streptozotocin-induced diabetic rats. Korean J Anesthesiol 61: 419-427, 2011
66. Parkington HC, Chow JA, Evans RG, Coleman HA, Tare M. Role for endothelium-derived hyperpolarizing factor in vascular tone in rat mesenteric and hindlimb circulations in vivo. J Physiol 542: 929-937, 2002.
67. Parkington HC, Coleman HA, Tare M. Prostacyclin and endotheliumdependent hyperpolarization. Pharmacol Res 49: 509-514, 2004.
68. Pieper GM. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 42: 204-213, 1999.
69. Rahimian R, Laher I, Dube G, van Breemen C. Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta. J Pharmacol Exp Ther 283: 116-122, 1997.
70. Rahimian R, Dube GP, Toma W, Dos Santos N, McManus BM, van Breemen C. Raloxifene enhances nitric oxide release in rat aorta via increasing endothelial nitric oxide mRNA expression. Eur J Pharmacol 434: 141-149, 2002.
71. Ren J, Ceylan-Isik AF. Diabetic cardiomyopathy: do women differ from men? Endocrine 25: 73-83, 2004.
72. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 250: H1145-H1149, 1986.
73. Sandow SL, Tare M, Coleman HA, Hill CE, Parkington HC. Involvement of myoendothelial gap junctions in the actions of endotheliumderived hyperpolarizing factor. Circ Res 90: 1108-1113, 2002.
74. Shen B, Ye CL, Ye KH, Liu JJ. Mechanism underlying enhanced endothelium-dependent vasodilatation in thoracic aorta of early stage streptozotocin-induced diabetic mice. Acta Pharmacol Sin 24: 422-428, 2003
75. Shi Y, Ku DD, Man RY, Vanhoutte PM. Augmented endotheliumderived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats. J Pharmacol Exp Ther 318: 276-281, 2006.
76. Shi Y, So KF, Man RY, Vanhoutte PM. Oxygen-derived free radicals mediate endothelium-dependent contractions in femoral arteries of rats with streptozotocin-induced diabetes. Br J Pharmacol 152: 1033-1041, 2007
77. Shi Y, Vanhoutte PM. Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br J Pharmacol 154: 639-651, 2008.
78. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, Takayanagi T, Nagao T, Egashira K, Fujishima M, Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 28: 703-711, 1996.
79. Snyder SH, Bredt DS. Biological roles of nitric oxide. Sci Am 266: 68-71, 74-67, 1992.
80. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105: 1429-1435, 2002.
81. Stankevicius E, Dalsgaard T, Kroigaard C, Beck L, Boedtkjer E, Misfeldt M, Nielsen G, Schjorring O, Hughes AD, Simonsen U. Opening of small and intermediate calcium-activated potassium channels induce relaxation mainly mediated by NO release in large arteries and EDHF in small arteries from rat. J Pharmacol Exp Ther 339: 842-850, 2011
82. Szocs K, Lassegue B, Sorescu D, Hilenski LL, Valppu L, Couse TL, Wilcox JN, Quinn MT, Lambeth JD, Griendling KK. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 22: 21-27, 2002.
83. Takenouchi Y, Kobayashi T, Taguchi K, Matsumoto T, Kamata K. Gender differences in vascular reactivity of aortas from streptozotocininduced diabetic mice. Biol Pharm Bull 33: 1692-1697, 2010.
84. Tare M, Parkington HC, Coleman HA, Neild TO, Dusting GJ. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature 346: 69-71, 1990.
85. Taylor PD, Oon BB, Thomas CR, Poston L. Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenalineinduced contractility in mesenteric resistance arteries from streptozotocininduced diabetic rats. Br J Pharmacol 111: 35-41, 1994.
86. Thompson J, Khalil RA. Gender differences in the regulation of vascular tone. Clin Exp Pharmacol Physiol 30: 1-15, 2003.
87. Tomioka H, Hattori Y, Fukao M, Sato A, Liu M, Sakuma I, Kitabatake A, Kanno M. Relaxation in different-sized rat blood vessels mediated by endothelium-derived hyperpolarizing factor: importance of processes mediating precontractions. J Vasc Res 36: 311-320, 1999.
88. Vanhoutte PM, Tang EH. Endothelium-dependent contractions: when a good guy turns bad! J Physiol 586: 5295-5304, 2008.
89. Vessieres E, Belin de Chantemele EJ, Toutain B, Guihot AL, Jardel A, Loufrani L, Henrion D. Cyclooxygenase-2 inhibition restored endothelium-mediated relaxation in old obese zucker rat mesenteric arteries. Front Physiol 1: 145, 2010.
90. Villar IC, Hobbs AJ, Ahluwalia A. Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor. J Endocrinol 197: 447-462, 2008.
91. Weston AH, Feletou M, Vanhoutte PM, Falck JR, Campbell WB, Edwards G. Bradykinin-induced, endothelium-dependent responses in porcine coronary arteries: involvement of potassium channel activation and epoxyeicosatrienoic acids. Br J Pharmacol 145: 775-784, 2005.
92. White RE, Carrier GO. Enhanced vascular α-adrenergic neuroeffector system in diabetes: importance of calcium. Am J Physiol Heart Circ Physiol 255: H1036-H1042, 1988.
93. White RE, Carrier GO. Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes. J Pharmacol Exp Ther 253: 1057-1062, 1990.
94. White RM, Rivera CO, Davison CA. Nitric oxide-dependent and-independent mechanisms account for gender differences in vasodilation to acetylcholine. J Pharmacol Exp Ther 292: 375-380, 2000.
95. Wigg SJ, Tare M, Tonta MA, O'Brien RC, Meredith IT, Parkington HC. Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery. Am J Physiol Heart Circ Physiol 281: H232-H240, 2001.
96. Wu Y, Huang A, Sun D, Falck JR, Koller A, Kaley G. Gender-specific compensation for the lack of NO in the mediation of flow-induced arteriolar dilation. Am J Physiol Heart Circ Physiol 280: H2456-H2461, 2001
97. 2+ in EDRF release in rat aorta. J Vasc Res 31: 18-24, 1994.
98. Zygmunt PM, Ryman T, Hogestatt ED. Regional differences in endothelium-dependent relaxation in the rat: contribution of nitric oxide and nitric oxide-independent mechanisms. Acta Physiol Scand 155: 257-266, 1995